n-methylscopolamine has been researched along with ketamine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aronstam, RS; Narayanan, L; Wenger, DA | 1 |
| Blake, DW; Korner, PI | 1 |
| Baldwin, R; Lumley, L; Niquet, J; Norman, K; Suchomelova, L; Wasterlain, CG | 1 |
3 other study(ies) available for n-methylscopolamine and ketamine
| Article | Year |
|---|---|
Ketamine inhibition of ligand binding to cholinergic receptors and ion channels.
Topics: Acetylcholine; Animals; Electric Organ; In Vitro Techniques; Ion Channels; Ketamine; Ligands; N-Methylscopolamine; Phencyclidine; Receptors, Cholinergic; Scopolamine Derivatives; Torpedo; Tubocurarine | 1982 |
Role of baroreceptor reflexes in the hemodynamic and heart rate responses to althesin, ketamine and thiopentone anesthesia.
Topics: Alfaxalone Alfadolone Mixture; Anesthesia, General; Animals; Aorta, Thoracic; Blood Pressure; Cardiac Output; Carotid Sinus; Efferent Pathways; Heart Rate; Hemodynamics; Ketamine; N-Methylscopolamine; Pressoreceptors; Rabbits; Reflex; Scopolamine Derivatives; Sympathetic Nervous System; Thiopental; Vascular Resistance | 1981 |
Midazolam-ketamine dual therapy stops cholinergic status epilepticus and reduces Morris water maze deficits.
Topics: Animals; Anticonvulsants; Brain; Cholinergic Agents; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Ketamine; Learning Disabilities; Lithium Chloride; Male; Maze Learning; Midazolam; N-Methylscopolamine; Pilocarpine; Rats; Rats, Sprague-Dawley; Status Epilepticus; Valproic Acid | 2016 |